Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Angela Genge & Adriano Chio. (2023) The future of ALS diagnosis and staging: where do we go from here?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 165-174.
Read now
Read now
C. A. Young, J. Ealing, C. J. McDermott, T. L. Williams, A. Al-Chalabi, T. Majeed, K. Talbot, T. Harrower, C. Faull, A. Malaspina, J. Annadale, R. J. Mills & A. Tennant. (2023) Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 82-90.
Read now
Read now
Eleftherios Anestis, Fiona J. R. Eccles, Ian Fletcher, Sofia Triliva & Jane Simpson. (2022) Healthcare professionals’ involvement in breaking bad news to newly diagnosed patients with motor neurodegenerative conditions: a qualitative study. Disability and Rehabilitation 44:25, pages 7877-7890.
Read now
Read now
. (2019) Theme 10 Disease stratification and phenotyping of patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:sup1, pages 289-300.
Read now
Read now
Francesca Palese, Arianna Sartori, Giancarlo Logroscino & Federica Edith Pisa. (2019) Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 176-185.
Read now
Read now
Anne Hogden, Geraldine Foley, Robert D Henderson, Natalie James & Samar M Aoun. (2017) Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare 10, pages 205-215.
Read now
Read now
Robert G. Miller & Stanley H. Appel. (2017) Introduction to supplement: the current status of treatment for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 1-4.
Read now
Read now
Ana Martinez, Maria del Valle Palomo Ruiz, Daniel I. Perez & Carmen Gil. (2017) Drugs in clinical development for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 26:4, pages 403-414.
Read now
Read now
Federica Agosta, Ammar Al-Chalabi, Massimo Filippi, Orla Hardiman, Ryuji Kaji, Vincent Meininger, Imaharu Nakano, Pamela Shaw, Jeremy Shefner, Leonard H. van den Berg & Albert Ludolph. (2015) The El Escorial criteria: Strengths and weaknesses. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:1-2, pages 1-7.
Read now
Read now
Sabrina Paganoni, Eric A. Macklin, Alexandra Lee, Alyssa Murphy, Judith Chang, Amanda Zipf, Merit Cudkowicz & Nazem Atassi. (2014) Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 453-456.
Read now
Read now
Jessica Mandrioli, Sara Biguzzi, Carlo Guidi, Elisabetta Venturini, Elisabetta Sette, Emilio Terlizzi, Alessandro Ravasio, Mario Casmiro, Fabrizio Salvi, Rocco Liguori, Romana Rizzi, Vladimiro Pietrini, Elisabetta Chierici, Mario Santangelo, Enrico Granieri, Vittoria Mussuto, Annamaria Borghi, Rita Rinaldi, Nicola Fini, Eleni Georgoulopoulou, Silvia De Pasqua, Marco Vinceti, Francesca Bonvicini, Salvatore Ferro & Roberto D’Alessandro. (2014) Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:3-4, pages 262-268.
Read now
Read now
Martin R. Turner, Robert Bowser, Lucie Bruijn, Luc Dupuis, Albert Ludolph, Michael McGrath, Giovanni Manfredi, Nicholas Maragakis, Robert G. Miller, Seth L. Pullman, Seward B. Rutkove, Pamela J. Shaw, Jeremy Shefner & Kenneth H. Fischbeck. (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup1, pages 19-32.
Read now
Read now
Michele Vitacca, Laura Comini, Giuliano Assoni, Domenico Fiorenza, Sonia Gilè, Palmira Bernocchi & Simonetta Scalvini. (2012) Tele-assistance in patients with amyotrophic lateral sclerosis: long term activity and costs. Disability and Rehabilitation: Assistive Technology 7:6, pages 494-500.
Read now
Read now
Articles from other publishers (71)
Kelly G. Gwathmey, Philippe Corcia, Chris J. McDermott, Angela Genge, Stefan Sennfält, Mamede de Carvalho & Caroline Ingre. (2023) Diagnostic delay in amyotrophic lateral sclerosis. European Journal of Neurology 30:9, pages 2595-2601.
Crossref
Crossref
Yuya Saito. (2023) Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis. Exploration of Neuroprotective Therapy, pages 186-206.
Crossref
Crossref
Vivek C. Velaga, Angus Cook, Kirsten Auret, Tom Jenkins, Geoff Thomas & Samar M. Aoun. (2023) Palliative and End-of-Life Care for People Living with Motor Neurone Disease: Ongoing Challenges and Necessity for Shifting Directions. Brain Sciences 13:6, pages 920.
Crossref
Crossref
Priya Treesa Thomas, Manjusha G Warrier, S Arun, B Bhuvaneshwari, Seena Vengalil, Saraswati Nashi, Veeramani Preethish-Kumar, Kiran Polavarapu, Prakashi Rajaram & Atchayaram Nalini. (2022) An individualised psychosocial intervention program for persons with MND/ALS and their families in low resource settings. Chronic Illness 19:2, pages 458-471.
Crossref
Crossref
Yizhe Song, Brad A. Racette, Alejandra Camacho-Soto & Susan Searles Nielsen. (2023) Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries. PLOS ONE 18:5, pages e0285011.
Crossref
Crossref
Jennifer C Davies, Thanuja Dharmadasa, Alexander G Thompson, Evan C Edmond, Katie Yoganathan, Jiali Gao, Kevin Talbot & Martin R Turner. (2023) Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis. Brain Communications 5:3.
Crossref
Crossref
Yoshihiro Kitaoka, Soju Seki, Sou Kawata, Akira Nishiura, Kohei Kawamura, Shin-ichiro Hiraoka, Mikihiko Kogo & Susumu Tanaka. (2023) Analysis of Feeding Behavior Characteristics in the Cu/Zn Superoxide Dismutase 1 (SOD1) SOD1G93A Mice Model for Amyotrophic Lateral Sclerosis (ALS). Nutrients 15:7, pages 1651.
Crossref
Crossref
John A. Morren, Carol Rheaume & Erik P. Pioro. (2023) Self-reported factors contributing to delay in ALS diagnosis among primary care providers in a large Ohio-based US healthcare network. Journal of the Neurological Sciences 445, pages 120532.
Crossref
Crossref
Catarina Falcão de Campos, Marta Gromicho, Hilmi Uysal, Julian Grosskreutz, Magdalena Kuzma-Kozakiewicz, Miguel Oliveira Santos, Susana Pinto, Susanne Petri, Michael Swash & Mamede de Carvalho. (2023) Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries. Frontiers in Neurology 13.
Crossref
Crossref
Jarrett Eshima, Samantha A. O’Connor, Ethan Marschall, Robert Bowser, Christopher L. Plaisier & Barbara S. Smith. (2023) Molecular subtypes of ALS are associated with differences in patient prognosis. Nature Communications 14:1.
Crossref
Crossref
Sara Alquati, Luca Ghirotto, Ludovica De Panfilis, Cristina Autelitano, Elisabetta Bertocchi, Giovanna Artioli, Francesca Sireci, Silvia Tanzi & Simona Sacchi. (2022) Negotiating the Beginning of Care: A Grounded Theory Study of Health Services for Amyotrophic Lateral Sclerosis. Brain Sciences 12:12, pages 1623.
Crossref
Crossref
Marina Boccardi, Ron Handels, Michael Gold, Alice Grazia, Michael W. Lutz, Mike Martin, Rachel Nosheny, Julie M. Robillard, Wendy Weidner, Jan Alexandersson, Jochen René Thyrian, Bengt Winblad, Paola Barbarino, Ara S. Khachaturian & Stefan Teipel. (2022) Clinical research in dementia: A perspective on implementing innovation. Alzheimer's & Dementia 18:11, pages 2352-2367.
Crossref
Crossref
Hiroshi Mitsumoto, Edward J. Kasarskis & Zachary Simmons. (2022) Hastening the Diagnosis of Amyotrophic Lateral Sclerosis. Neurology 99:2, pages 60-68.
Crossref
Crossref
Vinicius Stefani Borghetti, Vívian Pedigone Cintra, Jean de Oliveira Ramos, Vanessa Daccach Marques, Patrícia Toscano Onofre, Victor Augusto Souza Santana, Lua Flora Pereira Bezerra, Pedro José Tomaselli, André Cleriston José dos Santos, Claudia Ferreira da Rosa Sobreira & Wilson Marques Jr. (2022) Misdiagnoses in a Brazilian population with amyotrophic lateral sclerosis. Arquivos de Neuro-Psiquiatria 80:07, pages 676-680.
Crossref
Crossref
Emilia Castro-Rodríguez, Rafael Azagra, Xavier Gómez-Batiste & Mónica Povedano. (2021) La esclerosis lateral amiotrófica (ELA) desde la Atención Primaria. Epidemiología y características clínico-asistenciales. Atención Primaria 53:10, pages 102158.
Crossref
Crossref
Kjetil Bjornevik, Eilis J. O'ReillySamantha MolsberryLaurence N. KolonelLoic Le MarchandSabrina PaganoniMichael A. SchwarzschildPascal Benkert, Jens KuhleAlberto Ascherio. (2021) Prediagnostic Neurofilament Light Chain Levels in Amyotrophic Lateral Sclerosis. Neurology 97:15.
Crossref
Crossref
J.F. Vázquez-Costa, M. Martínez-Molina, M. Fernández-Polo, V. Fornés-Ferrer, M. Frasquet-Carrera & T. Sevilla-Mantecón. (2021) Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community. Neurología (English Edition) 36:7, pages 504-513.
Crossref
Crossref
J.F. Vázquez-Costa, M. Martínez-Molina, M. Fernández-Polo, V. Fornés-Ferrer, M. Frasquet-Carrera & T. Sevilla-Mantecón. (2021) Análisis del trayecto y retraso diagnóstico de los pacientes con esclerosis lateral amiotrófica en la Comunidad Valenciana. Neurología 36:7, pages 504-513.
Crossref
Crossref
Danielle Richards, John A. Morren & Erik P. Pioro. 2021. Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis
15
34
.
Anna Markella Antoniadi, Miriam Galvin, Mark Heverin, Orla Hardiman & Catherine Mooney. (2021) Prediction of caregiver quality of life in amyotrophic lateral sclerosis using explainable machine learning. Scientific Reports 11:1.
Crossref
Crossref
Marina Martínez-Molina, Herminia Argente-Escrig, Margarita F. Polo, David Hervás, Marina Frasquet, Victoria Cortés, Teresa Sevilla & Juan F. Vázquez-Costa. (2020) Early Referral to an ALS Center Reduces Several Months the Diagnostic Delay: A Multicenter-Based Study. Frontiers in Neurology 11.
Crossref
Crossref
Stefano Zoccolella, Antonella Mastronardi, Antonio Scarafino, Giovanni Iliceto, Eustachio D’Errico, Angela Fraddosio, Irene Tempesta, Antonella Morea, Gaspare Scaglione, Alessandro Introna & Isabella Laura Simone. (2020) Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype. Journal of Neurology 267:12, pages 3689-3695.
Crossref
Crossref
Danielle Richards, John A. Morren & Erik P. Pioro. (2020) Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 417, pages 117054.
Crossref
Crossref
Eleftherios Anestis, Fiona Eccles, Ian Fletcher, Maddy French & Jane Simpson. (2020) Giving and receiving a diagnosis of a progressive neurological condition: A scoping review of doctors’ and patients’ perspectives. Patient Education and Counseling 103:9, pages 1709-1723.
Crossref
Crossref
Pablo Bascuñana, Luisa Möhle, Mirjam Brackhan & Jens Pahnke. (2020) Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis. Drugs in R&D 20:3, pages 197-207.
Crossref
Crossref
Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Prerna Badhe, Amruta Paranjape, Radhika Pradhan, Rohit Das & Hema Biju. 2020. Novel Aspects on Motor Neuron Disease. Novel Aspects on Motor Neuron Disease.
Martin Matharan, Stéphane Mathis, Sarah Bonabaud, Louis Carla, Antoine Soulages & Gwendal Le Masson. (2020) Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners. Neurology Research International 2020, pages 1-8.
Crossref
Crossref
Anna Markella Antoniadi, Miriam Galvin, Mark Heverin, Orla Hardiman & Catherine Mooney. (2020) Prediction of caregiver burden in amyotrophic lateral sclerosis: a machine learning approach using random forests applied to a cohort study. BMJ Open 10:2, pages e033109.
Crossref
Crossref
Dale F. Sharrad & David W. Schultz. (2019) Factors contributing to delays in the diagnosis of motor neuron disease – A South Australian study. Journal of the Neurological Sciences 407, pages 116540.
Crossref
Crossref
Mohamed Mounir El Mendili, Giorgia Querin, Peter Bede & Pierre-François Pradat. (2019) Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts—Novel Techniques. Frontiers in Neurology 10.
Crossref
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Crossref
Koichi Tsunoda, Mihiro Takazawa, Tonghyo Chong & Yoko Morita. (2019) Slow, slurred speech as an initial complaint in amyotrophic lateral sclerosis. Auris Nasus Larynx 46:2, pages 193-195.
Crossref
Crossref
Antje A Seeber, A Jeannette Pols, Albert Hijdra, Hepke F Grupstra, Dick L Willems & Marianne de Visser. (2019) Experiences and reflections of patients with motor neuron disease on breaking the news in a two-tiered appointment: a qualitative study. BMJ Supportive & Palliative Care 9:1, pages e8-e8.
Crossref
Crossref
Yifang Bao, Liqin Yang, Yan Chen, Biyun Zhang, Haiqing Li, Weijun Tang, Daoying Geng & Yuxin Li. (2018) Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis. European Radiology 28:12, pages 4940-4948.
Crossref
Crossref
Ileana M. Howard & Nassim Rad. (2018) Electrodiagnostic Testing for the Diagnosis and Management of Amyotrophic Lateral Sclerosis. Physical Medicine and Rehabilitation Clinics of North America 29:4, pages 669-680.
Crossref
Crossref
F. Nobili, J. Arbizu, F. Bouwman, A. Drzezga, F. Agosta, P. Nestor, Z. Walker & M. Boccardi. (2018)
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
18
F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
. European Journal of Neurology 25:10, pages 1201-1217.
Crossref
Crossref
Anne Hogden, Samar M. Aoun & Peter L. Silbert. (2018) Palliative Care in Neurology: Integrating a Palliative Approach to Amyotrophic Lateral Sclerosis Care. EMJ Neurology, pages 68-76.
Crossref
Crossref
Cathleen Lutz. (2018) Mouse models of ALS: Past, present and future. Brain Research 1693, pages 1-10.
Crossref
Crossref
Tianzhi Yang, Laine Ferrill, Leanne Gallant, Sarah McGillicuddy, Tatiana Fernandes, Nicole Schields & Shuhua Bai. (2018) Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis. European Journal of Pharmaceutical Sciences 120, pages 30-39.
Crossref
Crossref
Matthew Salter, Emily Corfield, Aroul Ramadass, Francis Grand, Jayne Green, Jurjen Westra, Chun Ren Lim, Lucy Farrimond, Emily Feneberg, Jakub Scaber, Alexander Thompson, Lynn Ossher, Martin Turner, Kevin Talbot, Merit Cudkowicz, James Berry, Ewan Hunter & Alexandre Akoulitchev. (2018) Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis. EBioMedicine 33, pages 169-184.
Crossref
Crossref
Michael Benatar, Joanne Wuu, Peter M. Andersen, Vittoria Lombardi & Andrea Malaspina. (2018) Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Annals of Neurology 84:1, pages 130-139.
Crossref
Crossref
Wouter van Rheenen, Frank P. Diekstra, Oliver Harschnitz, Henk-Jan Westeneng, Kristel R. van Eijk, Christiaan G. J. Saris, Ewout J. N. Groen, Michael A. van Es, Hylke M. Blauw, Paul W. J. van Vught, Jan H. Veldink & Leonard H. van den Berg. (2018) Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLOS ONE 13:6, pages e0198874.
Crossref
Crossref
Matthew J. Fogarty. (2018) Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain Research Bulletin 140, pages 318-333.
Crossref
Crossref
Samar M. Aoun, Mary R. O'Brien, Lauren J. Breen & Margaret O'Connor. (2018) ‘The shock of diagnosis’: Qualitative accounts from people with Motor Neurone Disease reflecting the need for more person-centred care. Journal of the Neurological Sciences 387, pages 80-84.
Crossref
Crossref
Adrian J Wills, Juliet Colt & Roger Selby. (2017) Tracheostomy and salivary gland radiotherapy for severe sialorrhoea in motor neurone disease. Practical Neurology 17:5, pages 403-405.
Crossref
Crossref
Rui Jia, Stephanie Shepheard, Jiaoting Jin, Fangfang Hu, Xing Zhao, Li Xue, Li Xiang, Huaguang Qi, Qiumin Qu, Feng Guo, Mary-Louise Rogers & Jingxia Dang. (2017) Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort. Scientific Reports 7:1.
Crossref
Crossref
Ming-Dong Wang, Julian Little, James Gomes, Neil R. Cashman & Daniel Krewski. (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology 61, pages 101-130.
Crossref
Crossref
Miriam Galvin, Padhraig Ryan, Sinead Maguire, Mark Heverin, Caoifa Madden, Alice Vajda, Charles Normand & Orla Hardiman. (2017) The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs. PLOS ONE 12:6, pages e0179796.
Crossref
Crossref
Koen PoesenMaxim De SchaepdryverBeatrice StubendorffBenjamin GillePetra MuckovaSindy WendlerTino PrellThomas M. RingerHeidrun RhodeOlivier StevensKristl G. ClaeysGoedele CouwelierAnn D'HondtNikita LamairePetra TilkinDimphna Van ReijenSarah GourmaudNadin FedtkeBianka HeilingMatthias RumpelAnnekathrin RödigerAnne GunkelOtto W. WitteClaire PaquetRik VandenbergheJulian GrosskreutzPhilip Van Damme. (2017) Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88:24, pages 2302-2309.
Crossref
Crossref
Sarah Martin, Ahmad Al Khleifat & Ammar Al-Chalabi. (2017) What causes amyotrophic lateral sclerosis?. F1000Research 6, pages 371.
Crossref
Crossref
Pilar M. Ferraro, Federica Agosta, Nilo Riva, Massimiliano Copetti, Edoardo Gioele Spinelli, Yuri Falzone, Gianni Sorarù, Giancarlo Comi, Adriano Chiò & Massimo Filippi. (2017) Multimodal structural MRI in the diagnosis of motor neuron diseases. NeuroImage: Clinical 16, pages 240-247.
Crossref
Crossref
Patrick Weydt. 2017. Angewandte Ethik in der Neuromedizin. Angewandte Ethik in der Neuromedizin
63
71
.
Malabika Ghosh, Pauline Callagher, Robert Addison–Jones, Wendy Bennett, Amy Parkes, Suresh Chhetri & Tahir Majeed. (2016) Cognitive impairment in amyotrophic lateral sclerosis: the hidden challenges. British Journal of Neuroscience Nursing 12:1, pages 17-21.
Crossref
Crossref
Elena Ratti & James D. Berry. 2016. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry
685
712
.
Patrick Weydt, Patrick Oeckl, André Huss, Kathrin Müller, Alexander E. Volk, Jens Kuhle, Antje Knehr, Peter M. Andersen, Johannes Prudlo, Petra Steinacker, Jochen H. Weishaupt, Albert C. Ludolph & Markus Otto. (2016) Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Annals of Neurology 79:1, pages 152-158.
Crossref
Crossref
Xueping Chen & Hui-Fang Shang. (2015) New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis. Translational Neurodegeneration 4:1.
Crossref
Crossref
Boudewijn T H M Sleutjes, Inger Montfoort, Pieter A van Doorn, Gerhard H Visser & Joleen H Blok. (2015) Diagnostic accuracy of electrically elicited multiplet discharges in patients with motor neuron disease. Journal of Neurology, Neurosurgery & Psychiatry 86:11, pages 1234-1239.
Crossref
Crossref
Sabrina Paganoni, Chafic Karam, Nanette Joyce, Richard Bedlack & Gregory T. Carter. (2015) Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation 37:1, pages 53-68.
Crossref
Crossref
M. Galvin, C. Madden, S. Maguire, M. Heverin, A. Vajda, A. Staines & O. Hardiman. (2015) Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study. BMC Health Services Research 15:1.
Crossref
Crossref
Martin R. Turner & Michael Benatar. (2014) Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle & Nerve 51:1, pages 14-18.
Crossref
Crossref
Ricarda A. L. Menke, Sonja Körner, Nicola Filippini, Gwenaëlle Douaud, Steven Knight, Kevin Talbot & Martin R. Turner. (2014) Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 137:9, pages 2546-2555.
Crossref
Crossref
Hipolito Nzwalo, Daisy de Abreu, Michael Swash, Susana Pinto & Mamede de Carvalho. (2014) Delayed diagnosis in ALS: The problem continues. Journal of the Neurological Sciences 343:1-2, pages 173-175.
Crossref
Crossref
Sabrina Paganoni, Merit Cudkowicz & James D Berry. (2014) Outcome measures in amyotrophic lateral sclerosis clinical trials. Clinical Investigation 4:7, pages 605-618.
Crossref
Crossref
FUMIN WANG, YUCHENG LU, FAYING QI, QUANPING SU, LONG WANG, CUIPING YOU, FENGYUAN CHE & JIXU YU. (2014) Effect of the human SOD1-G93A gene on the Nrf2/ARE signaling pathway in NSC-34 cells. Molecular Medicine Reports 9:6, pages 2453-2458.
Crossref
Crossref
Tomer Fekete, Neta Zach, Lilianne R. Mujica-Parodi & Martin R. Turner. (2013) Multiple Kernel Learning Captures a Systems-Level Functional Connectivity Biomarker Signature in Amyotrophic Lateral Sclerosis. PLoS ONE 8:12, pages e85190.
Crossref
Crossref
James R Williams, David Fitzhenry, Lauren Grant, Derek Martyn & Douglas A Kerr. (2013) Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database. BMC Neurology 13:1.
Crossref
Crossref
Martin R Turner & Kevin Talbot. (2013) Mimics and chameleons in motor neurone disease. Practical Neurology 13:3, pages 153-164.
Crossref
Crossref
V. Cordesse, T. Jametal, C. Guy, S. Lefebvre, M. Roussel, J. Ruggeri, P. Schimmel, J. Holstein & V. Meininger. (2013) Analyse du parcours de santé au cours des maladies neurologiques handicapantes et évolutives. Revue Neurologique 169:6-7, pages 476-484.
Crossref
Crossref
Martin R Turner, Orla Hardiman, Michael Benatar, Benjamin R Brooks, Adriano Chio, Mamede de Carvalho, Paul G Ince, Cindy Lin, Robert G Miller, Hiroshi Mitsumoto, Garth Nicholson, John Ravits, Pamela J Shaw, Michael Swash, Kevin Talbot, Bryan J Traynor, Leonard H Van den Berg, Jan H Veldink, Steve Vucic & Matthew C Kiernan. (2013) Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology 12:3, pages 310-322.
Crossref
Crossref
Pat Doyle, Anna Brown, Valerie Beral, Gillian Reeves & Jane Green. (2012) Incidence of and risk factors for Motor Neurone Disease in UK women: a prospective study. BMC Neurology 12:1.
Crossref
Crossref
Robert Bowser, Martin R. Turner & Jeremy Shefner. (2011) Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nature Reviews Neurology 7:11, pages 631-638.
Crossref
Crossref